rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
2000-6-7
|
pubmed:abstractText |
Medulloblastoma is the most common malignant brain tumor of childhood. After treatment with surgery and radiation therapy, approximately 60% of children with medulloblastoma are alive and free of progressive disease 5 years after diagnosis, but many have significant neurocognitive sequelae. This study was undertaken to determine the feasibility and efficacy of treating children with nondisseminated medulloblastoma with reduced-dose craniospinal radiotherapy plus adjuvant chemotherapy.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0732-183X
|
pubmed:author |
pubmed-author:AllenJ CJC,
pubmed-author:BoyettJ MJM,
pubmed-author:CohenB HBH,
pubmed-author:GoldweinJJ,
pubmed-author:MuraszkoKK,
pubmed-author:NicholsonH SHS,
pubmed-author:PackerR JRJ,
pubmed-author:RorkeL BLB,
pubmed-author:SimL NLN,
pubmed-author:VezinaL GLG,
pubmed-author:WardW JWJ
|
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2127-36
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:10561268-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10561268-Cerebellar Neoplasms,
pubmed-meshheading:10561268-Chemotherapy, Adjuvant,
pubmed-meshheading:10561268-Child,
pubmed-meshheading:10561268-Child, Preschool,
pubmed-meshheading:10561268-Cisplatin,
pubmed-meshheading:10561268-Cranial Irradiation,
pubmed-meshheading:10561268-Disease-Free Survival,
pubmed-meshheading:10561268-Humans,
pubmed-meshheading:10561268-Lomustine,
pubmed-meshheading:10561268-Medulloblastoma,
pubmed-meshheading:10561268-Neoplasm Staging,
pubmed-meshheading:10561268-Radiation Dosage,
pubmed-meshheading:10561268-Survival Rate,
pubmed-meshheading:10561268-United States,
pubmed-meshheading:10561268-Vincristine
|
pubmed:year |
1999
|
pubmed:articleTitle |
Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.
|
pubmed:affiliation |
Departments of Neurology and Radiology, Children's National Medical Center, Washington, DC, USA. rpacker@cnmc.org
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't,
Multicenter Study
|